Correlation Between Hypera SA and Esperion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Hypera SA and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hypera SA and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hypera SA and Esperion Therapeutics, you can compare the effects of market volatilities on Hypera SA and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hypera SA with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hypera SA and Esperion Therapeutics.

Diversification Opportunities for Hypera SA and Esperion Therapeutics

-0.82

Correlation Coefficient

Hypera SA  Esperion Therapeutics

Pay attention - limited upside

The 3 months correlation between Hypera and Esperion is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Hypera SA and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Hypera SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hypera SA are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Hypera SA i.e., Hypera SA and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Hypera SA and Esperion Therapeutics

Assuming the 90 days horizon Hypera SA is expected to generate 0.78 times more return on investment than Esperion Therapeutics. However, Hypera SA is 1.29 times less risky than Esperion Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  290.00  in Hypera SA on December 29, 2024 and sell it today you would earn a total of  47.00  from holding Hypera SA or generate 16.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Hypera SA  vs.  Esperion Therapeutics

Hypera SA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Hypera SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile primary indicators, Hypera SA showed solid returns over the last few months and may actually be approaching a breakup point.

Esperion Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Esperion Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Hypera SA and Esperion Therapeutics

The main advantage of trading using opposite Hypera SA and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hypera SA position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.

The idea behind Hypera SA and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.